Articles in Business

Zacks.com

AstraZeneca Posts Positive Data on its Type II Diabetes Drug - Analyst Blog

Pipeline updates are highly awaited events in the pharma biotech sector as they play an important role in deciding whether or not to invest in a particular company. These updates provide... Read >>

Zacks.com

Is Align Technology (ALGN) Worth Adding to Your Portfolio? - Analyst Blog

On Sep 23, Zacks Investment Research upgraded Align Technology ( ALGN ) to a Zacks Rank #2 (Buy). Why the Upgrade? Align posted a mixed second quarter 2014 where earnings per share topped the... Read >>

Zacks.com

TripAdvisor (TRIP) Down on Viator Data Breach Concerns - Analyst Blog

Following news of a data breach at TripAdvisor 's ( TRIP ) recent acquisition, Viator, the travel information company's shares declined more than 4% to $94.29. Viator revealed that approximately... Read >>

Zacks.com

Terex (TEX) Hits 52-Week Low Following Trimmed Guidance - Analyst Blog

Shares of Terex Corp. ( TEX ) hit a 52 week low of $31.85 yesterday follwing the company's trimmed fiscal 2014 guidance due to weak crane demand. Shares of this Zacks Rank #4 (Sell) stock closed a... Read >>

Zacks.com

Anacor's Kerydin Launched in the US for Onychomycosis - Analyst Blog

Anacor Pharmaceuticals, Inc. ( ANAC ) announced that its Kerydin topical solution, 5% has been launched in the U.S. by partner Sandoz Inc., a Novartis ( NVS ) company. Kerydin is the first FDA... Read >>

Zacks.com

Dynavax (DVAX) Completes Enrolment for Study on Heplisav - Analyst Blog

Dynavax Technologies Corporation ( DVAX ) announced that it completed the planned enrolment in the ongoing clinical trial, HBV 23, on experimental hepatitis B vaccine, Heplisav B. We note that in... Read >>

Zacks.com

Supernus Confirms 2014 Outlook, Epilepsy Products in Focus - Analyst Blog

Supernus Pharmaceuticals, Inc. ( SUPN ) reaffirmed its 2014 guidance (announced on the second quarter 2014 earnings call) assuring that it will emerge profitable by year end. The company also... Read >>

Zacks.com

Citigroup Seeks U.S. Judge to Halt Argentine Bond Order - Analyst Blog

Caught between the Argentina government and a U.S. court order, Citigroup Inc. ( C ) is struggling for some reprieve. The bank is seeking U.S. District Judge Thomas Griesa to permit it to make... Read >>

Zacks.com

Bayer/Regeneron Successfully Expand Eylea Label in Japan - Analyst Blog

The HealthCare segment at Bayer ( BAYRY ) announced that its blockbuster eye treatment, Eylea, was approved for yet another indication in Japan. The drug was approved by the Ministry of Health,... Read >>

Zacks.com

Transocean Fleet Update: 2014 Out-of-Service Time Higher - Analyst Blog

Offshore drilling giant, Transocean Ltd. ( RIG ), has provided a fleet status report for the period commencing Aug 21, 2014 to date. The value of all the new deals and extensions in contracts,... Read >>